For some patients with peripheral artery disease, exercise can be impractical or impossible. Could the glucagon-like peptide-1 (GLP-1) agonists offer new hope for restoring movement and quality of life?

Guest Authors: Minitha Jacob, PharmD and Sherry Laguardia, PharmD, BCACP

Special Guest: Kristin Watson, PharmD, BCCP

Music by Good Talk

The BedMed study attempted to resolve a longstanding debate: Does the timing of administration for antihypertensive medication matter?  As it turns out, the timing of medication administration isn't terribly important so long as the medication is taken consistently.

Guest Authors:  Stefanie C. Nigro, PharmD, BCACP and Eric J MacLaughlin, PharmD, BCPS

Music by Good Talk

This iForumRx podcast episode, produced in collaboration with the ACCP Ambulatory Care Practice and Research Network (PRN), focuses on layered-learning and how to structure your practice to engage learners at different levels of experience.

Expert panelists Dr. Adenike Atanda-Oshikoya, Dr. Michelle Patterson, and Dr. Michelle Musser share their experiences working with students and residents.

Arm position can affect blood pressure accuracy. The ARMS study evaluated the effect of arm position on blood pressure readings, with implications for health care providers and patients with uncontrolled hypertension.

Guests: Emily Nuttall, PharmD, MBA and Tracie Eshelbrenner, PharmD, BCPS

Music by Good Talk

Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge because of its heterogeneous nature and the scarcity of therapies that meaningfully alter its course. The SUMMIT study evaluated the impact of tirzepatide on symptoms and mortality in people with HFpEF and obesity.

Guests: Jennifer N. Clements, Pharm.D., FCCP, FADCES, BCPS, BCACP, BC-ADM, CDCES and Dawn C. Fuke, Pharm.D., BCPS, BCACP

Music by Good Talk

This iForumRx podcast episode, produced in collaboration with the ACCP Ambulatory Care Practice and Research Network (PRN), focuses on the crucial role pharmacists can play in caring for the LGBTQIA+ community. The discussion highlights the unique healthcare needs and barriers faced by this community due to societal stigma.

Expert panelists Dr. Jordan Rowe, Dr. Sarah Amering, and Dr. Kevin Astle share their experiences in providing gender-affirming care and addressing health disparities. They discuss common health problems, medication considerations, and essential resources for pharmacists seeking to enhance their knowledge and expertise. The episode also addresses the impact of current political landscapes on patient access to care and how pharmacists can advocate for and support LGBTQIA+ individuals.

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong?

Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD

Music by Good Talk

Electronic cigarettes (e-cigarettes; also known as e-cigs, electronic nicotine delivery systems, vapes, mods, pods, and vape pens) have surged in popularity since their market introduction in 2007. Some view e-cigarettes as a less harmful alternative to traditional cigarettes and a potential harm reduction strategy. Others worry about their addictive potential and see them as a setback in our quest for a tobacco-free society.

Guest Authors: Elizabeth S. Yett, PharmD, BCACP, CTTS and Kirk E. Evoy, PharmD, BCACP, BC-ADM, CTTS

Music by Good Talk

Asthma and chronic obstructive pulmonary disease (COPD) are underdiagnosed due to the underuse of spirometry, underreporting of symptoms, and economic barriers.  Is there an effective way to capture undiagnosed but symptomatic patients and route them for appropriately managing their respiratory symptoms?  That's what the UCAP study attempted to answer.

Guest Authors:  Michelle Balli, PharmD, BCACP and Michelle Hernandez, PharmD

Music by Good Talk

Despite advances in the management of acute myocardial infarction (MI), up to 38% of patients will experience signs of heart failure (HF) and many have a reduced left ventricular ejection fraction (LVEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented cardiovascular benefits. However, data are limited regarding their use after an acute MI.

Guest Authors: Amy Hu, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP, CDCES

Music by Good Talk